Top compounds associated with response to CCDC169


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA Imatinib CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA SKI-II CTRPv2 pan-cancer AAC -0.12 0.001
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA BIX-01294 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.11 0.002
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC -0.13 0.002
mRNA Carboplatin CTRPv2 pan-cancer AAC -0.11 0.003
Download CSV